| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 20, 2013 | Alpha Street Research | Hunter Orr | CVS - CVS Caremark Corp - Upgraded to a Buy - Company Analysis and ASR Ranking Report | 9 | $24 | | May 19, 2013 | New Constructs, LLC | N/A | CVS: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 19, 2013 | Thomson Reuters Stock Report | StockReports + Research Department | Thomson Reuters Stock Report - CVS CAREMARK CORPORATION (CVS-N) | 12 | $25 | | May 19, 2013 | Pechala's Reports | Lubomir Pechala | CVS CORPORATION (CVS) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 19, 2013 | Stock Traders Daily | Thomas H Kee Jr. | Trading Report for (CVS). A detailed report, including free correlated market analysis, and updates. | 5 | $57.50 | | May 17, 2013 | S&P Capital IQ – STARS Reports | N/A | CVS Caremark Corp | 10 | $115 | | May 17, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for CVS Caremark Corporation | 43 | $494.50 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | CVS CORPORATION (CVS) 12-months forecast | 1 | $15 | | May 17, 2013 | Reuters Investment Profile | N/A | CVS Caremark Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 |
|
View All Reports for CVS ... |
|
|
0.46(0.77%) 4:00PM EDT|After Hours
:
58.95